May 032018
 

The Johnson and Johnson iMerge trial testing Geron’s Imetelstat for Myelodysplastic Syndrom was updated today (see https://clinicaltrials.gov/ct2/show/study/NCT02598661; obtained on 5-3-18).

The author owns shares of Geron.

 

The Hygiology Post ® welcomes feedback from readers as to whether the articles (individually and/or collectively) help fulfill its vision and mission.

 

Louis DeCola, Jr.  © 2018                                    The Hygiology Post ®